[1] Wu S*, He X*, Li M*, Shi F, Wu D, Pan M, Guo M, Zhang R, Luo S, Gu N, Dou J. MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2. Am J Transl Res. 2016 Dec 15;8(12):5433-5443. (*共同第一作者). 影响因子:3.146 (SCI)
[2] Dou J*, Ni Y*, He X*, Wu D, Li M, Wu S, Zhang R, Guo M, Zhao F. Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells. Am J Transl Res. 2016 Jan 15;8(1):98-108. (*共同第一作者). 影响因子: 3.402(SCI)
[3] Shi F*, Yang F*, He X*, Zhang Y, Wu S, Li M, Zhang Y, Di W, Dou J, Gu N. Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells. J Drug Target. 2016 Jan;24(1):34-46. (*共同第一作者).影响因子: 2.741(SCI)2.821
[4] Zhao F*, He X*, Wang Y*, Shi F, Wu D, Pan M, Li M, Wu S, Wang X, Dou J. Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties. Biosci Trends. 2015;9(5):325-34. (*共同第一作者). 影响因子: 1.663(SCI)
[5] Zhao F*, He X*, Sun J*, Wu D, Pan M, Li M, Wu S, Zhang R, Yan C, Dou J. Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastases. Am J Transl Res. 2015 Oct 15;7(10):1870-82. (*共同第一作者). 影响因子: 3.402(SCI)
[6] Wang X*, Zhao F*, He X*, Wang J, Zhang Y, Zhang H, Ni Y, Sun J, Wang X, Dou J. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine. Oncotarget. 2015 May 20; 6(14):12493-504. (*共同第一作者).影响因子: 6.359(SCI)
[7] Wang J*, Chen D*, He X*, Zhang Y, Shi F, Wu D, Chen J, Zhang Y, Zhao F, Dou J. Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition. Cancer Cell Int. 2015 Feb 25;15:24. doi: 10.1186/s12935-015-0174-4. (*共同第一作者).影响因子: 2.766(SCI)原1.989
[8] Wang X*, He X*, Zhao F*, Wang J, Zhang H, Shi F, Zhang Y, Cai K, Dou J. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis. J Transl Med. 2014 Mar 14;12:68. (*共同第一作者).影响因子: 3.991(SCI)
[9] Yang C*, He X*, Song L*, Zhan X, Zhang Y, Dou J, Gu N. γ-Fe2O3 Nanoparticles Increase Therapeutic Efficacy of Combination with Paclitaxel and Anti-ABCG2 Monoclonal Antibody on Multiple Myeloma Cancer Stem Cells in Mouse Model. J Biomed Nanotechnol. 2014 Feb;10(2):336-344. (*共同第一作者). 影响因子: 7.578(SCI)
[10] Dou J*, He X*, Liu Y*, Wang Y, Zhao F, Wang X, Chen D, Shi F, Wang J. Effect of downregulation of ZEB1 on vimentin expression, tumor migration and tumorigenicity of melanoma B16F10 cells and CSCs. Cell Biol Int. 2014 Apr;38(4):452-61. (*共同第一作者). 影响因子:1.635(SCI)
[11] He X, Wang J, Zhao F, Chen D, Chen J, Zhang H, Yang C, Liu Y, Dou J. ESAT-6-gpi DNA vaccine augmented the specific antitumor efficacy induced by the tumor vaccine B16F10-ESAT-6-gpi/IL-21 in a mouse model. Scand J Immunol. 2013 Jul;78(1):69-78. 影响因子:1.882(SCI)
[12] Dou J*, He XF*, Liu Y*, Huang Z, Yang C, Shi F, Chen D, Gu N. Targeted therapeutic effect of anti-ABCG2 antibody combined with nano silver and vincristine on mouse myeloma cancer stem cells. J Nanopart Res. 2013 Dec;15(12):1-12.(*共同第一作者). 影响因子:2.287(SCI)
[13] Dou J*, He XF*, Cao WH*, Zhao FS, Wang XY, Liu YR, Wang J. Overexpression of microRna-200c IN CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice. Cell Mol Biol (Noisy-le-grand). 2013 Oct 13;Suppl 59:OL1861-8(*共同第一作者).影响因子:0.691(SCI)
[14] He X, Wang J, Zhao F, Yu F, Chen D, Cai K, Yang C, Chen J, Dou J. Anti-tumor Efficacy of Viable Tumor Vaccine Modified by Heterogenetic ESAT-6 Antigen and Cytokine IL-21 in Melanomatous Mouse. Immunol Res. 2012 Jun;52(3):240-249. 影响因子:2.963(SCI)
[15] Hu W*, Wang J*, He X*, Zhang H, Yu F, Jiang L, Chen D, Chen J, Dou J. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnol Appl Biochem. 2011 Nov; 58(6):397-404. (*共同第一作者) 影响因子:1.534(SCI)